IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q1 2018 Holdings

Filed 2018-05-15 | 6 holdings | $39.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jounce Therapeutics, Inc.(JNCEEUR)Common481116101$14.8K662,06337.2%
Allena Pharmaceuticals(ALNAEUR)Common018119107$11.4K1,037,26728.7%
Protagonist Therapeutics, Inc.(PTGX)Common74366E102$8.4K982,27021.2%
Proteon Therapeutics Inc.Common74371L109$4.2K1,667,90710.5%
Argos Therapeutics Inc.Common040221103$744826,1531.9%
Argos Therapeutics Inc.CallCommon040221103$230256,0300.6%